US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals API Facility located at Karkhadi from January 13, 2020 to January 17, 2020. This was a scheduled pre-approval inspection and at the end of the inspection, the USFDA issued a Form 483 with two observations.
Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.